Gabrielle Munzer

Breakthrough Victoria is investing $1.7 million in Number 8 Bio, a leading innovator in sustainable agriculture technologies

Synthetic biology is a $30 billion opportunity creating 50,000 jobs according to CSIRO and its VC arm

CSIRO and Main Sequence's updated synthetic biology report projects a $30 billion annual sector and 50,000 jobs by 2040, citing startup capital raised, research grants, and the 2022 launch of UNSW Founders' SynBio 10x accelerator.

Australia's climate tech industry is booming, but it could bust without funds

Feature on Australia's fast-growing climate tech sector, recounting raises at companies including Neara, Loam Bio, Goterra and Great Wrap, and warning that scarce growth capital and limited foreign investment could stall the industry.

Main Sequence surpasses $1 billion funds under management for deep tech as it launches new Fund

Deep tech venture firm Main Sequence has reached an initial A$450 million close on its third fund, pushing money under management past A$1 billion; Hostplus, Temasek and CSIRO are among the backers.

Also SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Startup Daily·TechCrunch Australia·@AuManufacturing

Bondi GP and angel investor Dr Amandeep Hansra joins Main Sequence as principal

A Sydney GP who co-founded a medical investment syndicate has taken a principal role at a deep tech venture fund, joining shortly after another investor's promotion there.

Ignition Lane's Great Big Wrap: VCs court cash, an M&A bash & Canva makes a splash

Ignition Lane's weekly tech roundup covering fresh Australian startup raises, new venture funds and closes, a wave of acquisitions, delistings and a liquidation, executive moves, and Canva's product launch.

Also Techboard·Startup Daily

What makes a great venture partner?

Main Sequence announces Gabrielle Munzer's promotion to its first Partner, tracing her journey from capital markets through Senior Associate and Principal roles and the signals the firm values in venture partners.

Main Sequence announces new Partner, Gabrielle Munzer, to build companies with biology

Australia's Main Sequence fund promotes Gabrielle Munzer to Partner to lead its biotech push; the article also covers her finance background, the firm's company-building model, a UNSW accelerator, and recent diverse hires.

CSIRO's VC fund Main Sequence is backing biotech startups in a new UNSW accelerator

UNSW Founders is launching SynBio 10x, a synthetic biology accelerator run with Main Sequence, CSIRO's venture arm, which plans $120,000 per startup plus UNSW's $20,000; applications close May 15.

The Genealogy of Samsara Eco

Main Sequence recounts how personal relationships across CSIRO, Woolworths, ANU and prior ventures converged over years to found plastic-recycling startup Samsara Eco.